Vol 7, Supplement 4 (September 18, 2018): Translational Andrology and Urology (Personalized Prostate Cancer Care)

Preface

Personalized prostate cancer care

Soroush Rais-Bahrami, Jennifer B. Gordetsky

Translational Andrology and Urology

2018;

(Suppl 4)

:S383

(18 September 2018)

PDF Full Text (1448) Open Access

Original Article

Improving risk stratification in a community-based African American population using cell cycle progression score

Walter Rayford, Mark Greenberger, Randy V. Bradley

Translational Andrology and Urology

2018;

(Suppl 4)

:S384-S391

(18 September 2018)

PDF Full Text (2237) Open Access

Detection of extraprostatic disease and seminal vesicle invasion in patients undergoing magnetic resonance imaging-targeted prostate biopsies

Erin M. Baumgartner, Kristin K. Porter, Jeffrey W. Nix, Soroush Rais-Bahrami, Jennifer B. Gordetsky

Translational Andrology and Urology

2018;

(Suppl 4)

:S392-S396

(18 September 2018)

PDF Full Text (2741) Open Access

Review Article

Rethinking active surveillance for prostate cancer in African American men

Gabriel Z. Leinwand, Andrew T. Gabrielson, Louis S. Krane, Jonathan L. Silberstein

Translational Andrology and Urology

2018;

(Suppl 4)

:S397-S410

(18 September 2018)

PDF Full Text (2287) Open Access

MRI findings guiding selection of active surveillance for prostate cancer: a review of emerging evidence

Zachary A. Glaser, Kristin K. Porter, John V. Thomas, Jennifer B. Gordetsky, Soroush Rais-Bahrami

Translational Andrology and Urology

2018;

(Suppl 4)

:S411-S419

(18 September 2018)

PDF Full Text (2794) Open Access

Prostate imaging features that indicate benign or malignant pathology on biopsy

Catherine Elizabeth Lovegrove, Mudit Matanhelia, Jagpal Randeva, David Eldred-Evans, Henry Tam, Saiful Miah, Mathias Winkler, Hashim U. Ahmed, Taimur T. Shah

Translational Andrology and Urology

2018;

(Suppl 4)

:S420-S435

(18 September 2018)

PDF Full Text (45904) Open Access

Urinary markers aiding in the detection and risk stratification of prostate cancer

Nicholas Raja, Christopher M. Russell, Arvin K. George

Translational Andrology and Urology

2018;

(Suppl 4)

:S436-S442

(18 September 2018)

PDF Full Text (3181) Open Access

Entering an era of radiogenomics in prostate cancer risk stratification

Nachiketh Soodana-Prakash, Radka Stoyanova, Abhishek Bhat, Maria C. Velasquez, Omer E. Kineish, Alan Pollack, Dipen J. Parekh, Sanoj Punnen

Translational Andrology and Urology

2018;

(Suppl 4)

:S443-S452

(18 September 2018)

PDF Full Text (3530) Open Access

Ultra-small superparamagnetic iron oxide contrast agents for lymph node staging of high-risk prostate cancer

Marcin Czarniecki, Filippo Pesapane, Bradford J. Wood, Peter L. Choyke, Baris Turkbey

Translational Andrology and Urology

2018;

(Suppl 4)

:S453-S461

(18 September 2018)

PDF Full Text (2987) Open Access

Role of PET imaging for biochemical recurrence following primary treatment for prostate cancer

Samuel J. Galgano, Roberto Valentin, Jonathan McConathy

Translational Andrology and Urology

2018;

(Suppl 4)

:S462-S476

(18 September 2018)

PDF Full Text (4670) Open Access

Clinical significance of subtypes of Gleason pattern 4 prostate cancer

Oudai Hassan, Andres Matoso

Translational Andrology and Urology

2018;

(Suppl 4)

:S477-S483

(18 September 2018)

PDF Full Text (8845) Open Access

Percent Gleason pattern 4 in stratifying the prognosis of patients with intermediate-risk prostate cancer

Meenal Sharma, Hiroshi Miyamoto

Translational Andrology and Urology

2018;

(Suppl 4)

:S484-S489

(18 September 2018)

PDF Full Text (19344) Open Access

Linking cellular metabolism and metabolomics to risk-stratification of prostate cancer clinical aggressiveness and potential therapeutic pathways

Eric Eidelman, Hemantkumar Tripathi, De-Xue Fu, M. Minhaj Siddiqui

Translational Andrology and Urology

2018;

(Suppl 4)

:S490-S497

(18 September 2018)

PDF Full Text (2118) Open Access

Developing a personalized template for lymph node dissection during radical prostatectomy

Ram A. Pathak, Ashok K. Hemal

Translational Andrology and Urology

2018;

(Suppl 4)

:S498-S504

(18 September 2018)

PDF Full Text (3533) Open Access

Emerging role of cytoreductive prostatectomy in patients with metastatic disease

Yasmeen Jaber, Chad A. Reichard, Brian F. Chapin

Translational Andrology and Urology

2018;

(Suppl 4)

:S505-S513

(18 September 2018)

PDF Full Text (2637) Open Access

Technical Note

Nitrocellulose tissue prints: an innovative approach to preparing high quality DNA and RNA from prostate biopsies without compromising the cores for pathology diagnosis

Sandra M. Gaston, William E. Grizzle, Soroush Rais-Bahrami, Gary P. Kearney

Translational Andrology and Urology

2018;

(Suppl 4)

:S514-S518

(18 September 2018)

PDF Full Text (2088) Open Access

Editorial

Optimizing patient selection for focal therapy—mapping and ablating the index lesion

James S. Wysock, Herbert Lepor

Translational Andrology and Urology

2018;

(Suppl 4)

:S519-S525

(18 September 2018)

PDF Full Text (6913) Open Access

Disclosure:

The supplement “Personalized Prostate Cancer Care” was commissioned by the editorial office, Translational Andrology and Urology without any sponsorship or funding. Soroush Rais-Bahrami and Jennifer B. Gordetsky served as the unpaid Guest Editors for the supplement.